IGC Pharma Secures North American Composition Protection for IGC-AD1 as Phase 2 CALMA Enrollment Advances February 17, 2026 Read More »
IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets February 12, 2026 Read More »
